Topic prioritisation

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Decision date

Decision date

Prioritisation programme

Prioritisation programme

Decision

Decision

Showing 1 to 8 of 8

TitlePrioritisation programmeDecisionDecision date
Henlius (pertuzumab biosimilar) for treating HER2-positive breast cancer [TS ID 12094]None selectedNot selected
Secukinumab biosimilar for treating plaque psoriasis [TSID11992]None selectedNot selected
Avtozma (tocilizumab biosimilar) for treating moderate to severe rheumatoid arthritis in people aged 18 to 75 [TSID11848]None selectedNot selected
CT-P39 (omalizumab biosimilar) for previously treated chronic spontaneous urticaria [TSID11832]None selectedNot selected
ABP-654 (ustekinumab biosimilar) for previously treated moderate to severe plaque psoriasis [TSID11790]None selectedNot selected
CT-P43 (ustekinumab biosimilar) for treating moderate to severe plaque psoriasis [TSID11773]None selectedNot selected
ABP 959 (eculizumab biosimilar) for treating paroxysmal nocturnal haemoglobinuria [TSID10250]None selectedNot selected
TVB-009 (denosumab biosimilar) for treating postmenopausal osteoporosis in people aged 60 to 90 [TSID11807]None selectedNot selectedTBC

Results per page

  1. 10
  2. 25
  3. 50
  4. All